Cha University

This study tests a new mix of four drugs (gemcitabine, cisplatin, nab-paclitaxel, and tislelizumab) in people with advanced bile duct cancer that hasn't been treated before. The goal is to see if this combination can shrink tumors and help people live longer. About 61 adults will…

This early-phase trial tests a new treatment for glioblastoma, a fast-growing brain cancer. After standard surgery, patients receive a single dose of special stem cells that carry a 'suicide gene' directly into the tumor site. The goal is to see if this approach is safe and can k…

This study tests a new approach for people who recently had a heart attack and received a stent. Instead of taking two blood thinners (aspirin plus another drug), participants will take only one blood thinner (ticagrelor) plus a low dose of colchicine, a drug typically used for g…

This study tests whether an AI-assisted ECG reading is as safe and effective as the usual approach for quickly deciding if a patient with chest pain is having a heart attack. About 4,670 adults with chest pain suspicious for a heart attack will be randomly assigned to either AI-g…

This study is testing whether a simple blood test that looks for tumor DNA (ctDNA) can find genetic changes in advanced bile duct cancer as well as a traditional tissue biopsy. The goal is to make it easier and less invasive for doctors to choose targeted treatments. The study wi…

This study is testing whether a blood test that looks for tumor DNA (ctDNA) can find genetic changes in advanced bile duct cancer as well as a traditional tissue biopsy does. Researchers will enroll 200 adults with advanced biliary tract cancer across multiple hospitals in Korea.…

This study is for people with advanced biliary tract cancer (a type of bile duct cancer) who are scheduled to receive a combination of two drugs, lenvatinib and pembrolizumab. Researchers want to find genetic markers in blood and tumor samples that might predict how well a person…